Earnings Call · Q4 FY2024·2025-02-04

Q4 24EPS +7.86%·Rev n/aQ3 24EPS +6.50%·Rev n/aQ2 24EPS +8.85%·Rev n/aQ1 24EPS -5.45%·Rev n/a⚠ consensus missing

REGENERON PHARMACEUTICALS, INC. REGN

+4.5%1d on move date+3.9% vs SPY3d+8.3%5d+3.5%

Research tier

Behavioral profile computed for this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more REGN calls or request research access.

More REGN calls Browse calls Request research access